NASDAQ
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a free cash flow growth of -32.97% as of Friday, May 29, 2026. This represents a 1338.02% decrease compared to its 12-month average of 2.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.